GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Standard Chem & Pharm Co 1720.TW · TWD

Health Care · Taiwan Stock Exchange · 🇹🇼 Taiwan

Compare

55.10

-0.36%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Popular Bitcoin Ethereum Nvidia Apple S&P 500 Gold EUR/USD US 10Y

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 7.02bn

FY2016FY2025

Net income

TWD 927.7m

FY2016FY2025

Free cash flow

TWD 1.38bn

FY2016FY2025

Shareholders' equity

TWD 6.12bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueTWD 7.02bnTWD 6.79bnTWD 6.24bnTWD 5.85bnTWD 4.60bnTWD 4.31bnTWD 3.94bnTWD 3.57bnTWD 3.85bnTWD 3.67bn
Gross profitTWD 2.91bnTWD 2.99bnTWD 2.73bnTWD 2.49bnTWD 2.07bnTWD 1.92bnTWD 1.71bnTWD 1.54bnTWD 1.75bnTWD 1.58bn
Research and developmentTWD 257.7mTWD 288.1mTWD 266.3mTWD 251.9mTWD 241.8mTWD 227.2mTWD 225.8mTWD 224.9mTWD 239.6mTWD 241.1m
Operating incomeTWD 1.36bnTWD 1.40bnTWD 1.26bnTWD 1.44bnTWD 1.02bnTWD 774.1mTWD 590.2mTWD 407.8mTWD 548.0mTWD 421.7m
Net incomeTWD 927.7mTWD 880.5mTWD 834.9mTWD 1.15bnTWD 706.7mTWD 524.2mTWD 376.5mTWD 374.4mTWD 363.3mTWD 340.2m
Diluted earnings per share3.784.944.666.443.952.942.122.102.041.90

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsTWD 11.80bnTWD 11.18bnTWD 11.19bnTWD 10.97bnTWD 10.10bnTWD 7.05bnTWD 6.93bnTWD 6.44bnTWD 6.37bnTWD 6.23bn
Cash and short-term investmentsTWD 2.39bnTWD 1.81bnTWD 2.28bnTWD 2.60bnTWD 2.99bnTWD 1.48bnTWD 1.69bnTWD 1.45bnTWD 1.41bnTWD 1.16bn
Total liabilitiesTWD 2.51bnTWD 2.20bnTWD 3.05bnTWD 3.53bnTWD 3.30bnTWD 2.14bnTWD 2.28bnTWD 2.19bnTWD 2.17bnTWD 2.03bn
DebtTWD 930.0mTWD 560.4mTWD 1.33bnTWD 1.79bnTWD 1.67bnTWD 785.2mTWD 1.02bnTWD 947.3mTWD 937.3mTWD 622.7m
Shareholders' equityTWD 6.12bnTWD 5.91bnTWD 5.30bnTWD 4.75bnTWD 4.34bnTWD 3.97bnTWD 3.76bnTWD 3.68bnTWD 3.67bnTWD 3.72bn
Shares outstanding246m178m179m179m179m178m177m178m178m179m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsTWD 1.87bnTWD 1.69bnTWD 1.34bnTWD 1.23bnTWD 827.0mTWD 922.6mTWD 637.9mTWD 484.9mTWD 708.7mTWD 305.4m
Capital spending−TWD 489.3m−TWD 599.6m−TWD 625.7m−TWD 1.20bn−TWD 217.9m−TWD 352.5m−TWD 179.1m−TWD 169.4m−TWD 385.6m−TWD 177.9m
Free cash flowTWD 1.38bnTWD 1.10bnTWD 710.8mTWD 30.3mTWD 609.1mTWD 570.1mTWD 458.8mTWD 315.6mTWD 323.1mTWD 127.5m
Dividends paid−TWD 500.3m−TWD 482.5m−TWD 446.7m−TWD 446.7m−TWD 321.7m−TWD 268.0m−TWD 268.0m−TWD 285.9m−TWD 178.7m−TWD 178.7m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueTWD 1.87bnTWD 1.65bnTWD 1.79bnTWD 1.77bnTWD 1.83bnTWD 1.64bnTWD 1.67bnTWD 1.74bn
Gross profitTWD 821.7mTWD 720.6mTWD 736.0mTWD 737.4mTWD 735.3mTWD 700.2mTWD 739.6mTWD 744.7m
Operating incomeTWD 407.9mTWD 343.6mTWD 352.8mTWD 348.8mTWD 343.9mTWD 314.1mTWD 335.5mTWD 350.7m
Net incomeTWD 258.6mTWD 231.5mTWD 229.2mTWD 307.6mTWD 196.2mTWD 194.7mTWD 194.6mTWD 217.4m
Diluted earnings per share0.780.700.931.250.800.791.091.22
Cash from operationsTWD 139.0mTWD 358.0mTWD 572.0mTWD 510.0mTWD 445.0mTWD 285.0mTWD 540.0mTWD 684.0m
Capital spending−TWD 126.0m−TWD 131.0m−TWD 120.0m−TWD 78.0m−TWD 131.0m−TWD 171.0m−TWD 237.0m−TWD 85.0m
Free cash flowTWD 13.0mTWD 227.0mTWD 452.0mTWD 432.0mTWD 314.0mTWD 114.0mTWD 303.0mTWD 599.0m
Total assetsTWD 12.32bnTWD 12.10bnTWD 11.80bnTWD 11.62bnTWD 11.59bnTWD 11.41bnTWD 11.18bnTWD 11.16bn
Cash and short-term investmentsTWD 2.32bnTWD 2.38bnTWD 2.39bnTWD 2.18bnTWD 1.98bnTWD 1.96bnTWD 1.81bnTWD 1.73bn
DebtTWD 837.1mTWD 918.3mTWD 955.8mTWD 1.07bnTWD 563.9mTWD 658.9mTWD 717.5mTWD 869.0m
Shareholders' equityTWD 6.19bnTWD 6.04bnTWD 6.12bnTWD 5.95bnTWD 5.68bnTWD 5.61bnTWD 5.91bnTWD 5.91bn

Financial ratios

Data as of 4 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin41.4%44.0%43.7%42.5%44.9%44.6%
Operating margin19.4%20.6%20.2%24.6%22.2%18.0%
Net margin13.2%13.0%13.4%19.7%15.4%12.2%
Return on equity15.1%14.9%15.8%24.3%16.3%13.2%
Return on assets7.9%7.9%7.5%10.5%7.0%7.4%
Free cash flow yield17.1%23.0%19.6%24.2%10.4%12.8%
Revenue growth3.4%8.8%6.6%27.1%6.9%9.4%
Earnings growth5.4%5.5%-27.6%63.2%34.8%39.2%
Current ratio2.53x3.01x2.29x1.94x2.13x2.18x
Debt to equity0.15x0.12x0.21x0.42x0.40x0.20x
Equity ratio51.9%52.8%47.4%43.3%43.0%56.3%
Interest coverage161.32x92.66x48.83x76.51x140.96x102.23x
R&D as a share of sales3.7%4.2%4.3%4.3%5.3%5.3%
Buybacks as a share of market value-37.9%0.4%0.0%-0.0%-0.3%-0.6%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue6.3%10.3%7.8%
Operating income-1.7%12.0%13.5%
Net income-7.0%12.1%10.3%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin42.7%42.9%43.4%43.6%
Operating margin20.0%21.1%20.8%18.1%
Net margin13.1%14.7%14.4%12.8%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings14.211.412.88.79.911.714.413.716.015.6
Price to sales1.91.51.71.71.51.41.41.41.51.4

Dividends and splits

Per share, in the currency the company pays

Paid for 26 years. Last went ex-dividend on 23 Jul 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year2.002.5452.4552.2732.2731.6361.3641.364
  • 1.07-for-1 split · 19 Aug 2011
  • 1.03-for-1 split · 20 Jul 2009
  • 1.03-for-1 split · 18 Aug 2006
  • 1-to-1 reverse split · 29 Dec 2005
  • 1.03-for-1 split · 14 Aug 2003
  • 21-for-20 split · 7 Aug 2002

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.